Anterogen안트로젠
065660 · KOSDAQ · ₩065660 · 안트로젠
₩13,360▼ ₩720 (5.11%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩2.2B | ₩2.1B | ₩2B | ₩2B | ₩1.9B | ₩1.6B | ₩1.8B | ₩1.9B |
| Cost of sales | ₩1.5B | ₩1.4B | ₩1.3B | ₩1.3B | ₩1.2B | ₩1.1B | ₩1.1B | ₩1.2B |
| Gross profit | ₩701M | ₩716M | ₩708M | ₩733M | ₩672M | ₩551M | ₩667M | ₩705M |
| Operating income | −₩478M | −₩1.1B | −₩475M | −₩407M | −₩455M | −₩1.1B | −₩1.3B | −₩639M |
| Net income | ₩732M | −₩882M | −₩1.3B | ₩11M | ₩609M | −₩699M | −₩2.1B | ₩356M |
| Net income to shareholders | ₩732M | −₩882M | −₩1.3B | ₩11M | ₩609M | −₩699M | −₩2.1B | ₩356M |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩83B | ₩85B | ₩88B | ₩91B | ₩92B | ₩96B | ₩116B | ₩116B |
| Current assets | ₩49B | ₩48B | ₩48B | ₩49B | ₩49B | ₩50B | ₩45B | ₩46B |
| Cash and equivalents | ₩1.7B | ₩1.7B | ₩1.6B | ₩2B | ₩1.6B | ₩1.7B | ₩1.5B | ₩1.6B |
| Total liabilities | ₩2.2B | ₩959M | ₩813M | ₩1.4B | ₩1.1B | ₩1.9B | ₩5.9B | ₩3.4B |
| Current liabilities | ₩2B | ₩750M | ₩618M | ₩1.2B | ₩958M | ₩1.7B | ₩1.5B | ₩975M |
| Borrowings | — | — | — | — | — | — | — | ₩0 |
| Total equity | ₩80B | ₩84B | ₩87B | ₩90B | ₩91B | ₩94B | ₩110B | ₩113B |
| Shareholders' equity | ₩80B | ₩84B | ₩87B | ₩90B | ₩91B | ₩94B | ₩110B | ₩113B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | ₩1.9M | −₩813M | −₩585M | ₩282M | −₩135M | −₩582M | −₩385M | −₩846M |
| Capital spending | ₩143M | ₩83M | ₩19M | ₩9.4M | ₩36M | ₩33M | ₩97M | ₩50M |
| Free cash flow | −₩141M | −₩896M | −₩604M | ₩273M | −₩171M | −₩615M | −₩482M | −₩896M |
Consolidated where available. Amounts in won.
Also known as: Anterogen / 안트로젠 / 065660 / KRX:065660
Source: KRX statistical information